MedTrace Logo

Study of Psychopathological Characteristics of Patient Smoking in Thoracic Oncology

NCT01955057 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2016-06-09

No results posted yet for this study

Summary

Persistent smoking after lung cancer has been the subject of medical, therapeutic and epidemiological publications for twenty years of research. Continued persistent smoking is all the more a problem for oncologists as there is evidence that smoking cessation, with lung cancer, gives therapeutic benefit. Quitting smoking can improve the response to treatments (chemotherapy, radiotherapy, surgery), quality of life and overall survival. However many patients refuse adhesion to tobacco cessation. Daily practice leads us to the hypothesis that adhesion differences aren't related to the denial of medical information, nor to resignation or to nicotine dependence. Patients who continue smoking seem to face a form of impossibility to wean. Cigarette seems to be felt as a part of their body in their narration and description of their body image.

Conditions

  • Smoking Cessation and Lung Cancer

Interventions

BEHAVIORAL

Research interviews

BEHAVIORAL

Tests (Fagerström, Q-MAT, H.A.D.S, SCL 90-R)

BEHAVIORAL

Projective methods (Thematic apperception Test, Rorschach)

BEHAVIORAL

Carbon monoxide test

Sponsors & Collaborators

  • University Hospital, Strasbourg, France

    lead OTHER

Principal Investigators

  • Jonathan GRAFFI · Hôpitaux Universitaires de Strasbourg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01955057 on ClinicalTrials.gov